Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial. - Hall A; Croft J; Walker K; Boyd K; Roberts S; Holroyd A; Garg M; Ferris E; Cook G; Pierceall WE; Thakurta A; Gandhi A; et al. (British journal of haematology, 2026)